SILVER SPRING, Md., Jan. 10, 2024 (GLOBE NEWSWIRE) — Elutia Inc. (Nasdaq: ELUT) today announced that it has regained compliance with Nasdaq’s market value of listed securities requirement and majority independent board requirement. As a result, the Company now...
510(k) filing follows FDA feedback from successful pre-submission meeting SILVER SPRING, Md., Dec. 18, 2023 (GLOBE NEWSWIRE) — Elutia Inc. (Nasdaq: ELUT) today announced it has submitted a 510(k) premarket notification to the U.S. Food and Drug Administration...
– Company Now Focused on Proprietary Drug-Eluting Biomatrix Platform – SILVER SPRING, Md., Nov. 09, 2023 (GLOBE NEWSWIRE) — Elutia Inc. (Nasdaq: ELUT) (“Elutia”), a company pioneering drug-eluting biomatrix products, today announced it completed the...
SILVER SPRING, Md., Nov. 06, 2023 (GLOBE NEWSWIRE) — Elutia Inc. (Nasdaq: ELUT) (“Elutia”), a company pioneering drug-eluting biomatrix products, today announced that it will release its third quarter 2023 financial results after market close on Monday, November...
